Michele Gruber Maintains 365K Share Stake in Lipella Pharma
Ticker: LIPO · Form: SC 13G/A · Filed: Feb 7, 2024 · CIK: 1347242
| Field | Detail |
|---|---|
| Company | Lipella Pharmaceuticals Inc. (LIPO) |
| Form Type | SC 13G/A |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, amendment, beneficial-ownership
TL;DR
**Michele Gruber still owns 365,000 shares of Lipella Pharma, showing a solid individual stake.**
AI Summary
Michele Gruber, an individual, filed an amended SC 13G/A on February 7, 2024, disclosing her beneficial ownership of 365,000 shares of Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) common stock as of December 31, 2023. This represents a significant stake, giving her sole voting and dispositive power over these shares. This matters to investors because it shows a key individual's continued substantial ownership in the company, potentially signaling confidence or influence over corporate decisions.
Why It Matters
This filing indicates a significant individual shareholder's continued commitment to Lipella Pharmaceuticals, which can be a positive signal for other investors regarding the company's stability and future prospects.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous disclosure and shows a stable ownership position, indicating low immediate risk.
Analyst Insight
Investors should note Michele Gruber's continued substantial ownership as a potential indicator of insider confidence, but further research into the company's financials and strategic direction is warranted before making investment decisions.
Key Numbers
- 365,000 — Shares Beneficially Owned (Represents Michele Gruber's sole voting and dispositive power over Lipella Pharmaceuticals Inc. common stock as of December 31, 2023.)
- $0.0001 — Par Value per Share (The stated par value of Lipella Pharmaceuticals Inc. common stock.)
- December 31, 2023 — Date of Event (The date as of which the beneficial ownership information in the filing is reported.)
Key Players & Entities
- Michele Gruber (person) — Reporting Person, beneficial owner of shares
- Lipella Pharmaceuticals Inc. (company) — Issuer of the securities
- 365,000 (dollar_amount) — Number of shares beneficially owned by Michele Gruber
Forward-Looking Statements
- Michele Gruber will maintain a significant ownership stake in Lipella Pharmaceuticals Inc. for the foreseeable future. (Michele Gruber) — medium confidence, target: December 31, 2024
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person in this SC 13G/A filing is Michele Gruber, identified with CIK 0001971374.
What is the name of the issuer whose securities are being reported?
The issuer of the securities is Lipella Pharmaceuticals Inc., with CIK 0001347242.
How many shares of Lipella Pharmaceuticals Inc. common stock does Michele Gruber beneficially own?
Michele Gruber beneficially owns 365,000 shares of Lipella Pharmaceuticals Inc. common stock, as stated in Item 9 of the filing.
What type of power does Michele Gruber have over the beneficially owned shares?
Michele Gruber has sole voting power over 365,000 shares and sole dispositive power over 365,000 shares, as detailed in Items 5 and 7 of the filing.
What was the 'Date of Event' that required this filing?
The 'Date of Event which Requires Filing of this Statement' was December 31, 2023, as specified on the cover page of the filing.
Filing Stats: 970 words · 4 min read · ~3 pages · Grade level 8.3 · Accepted 2024-02-07 17:29:28
Key Financial Figures
- $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securitie
Filing Documents
- g084014_sc13ga.htm (SC 13G/A) — 30KB
- 0001753926-24-000245.txt ( ) — 32KB
Names of Persons Filing
Item 2. Names of Persons Filing: (a) Name of Person Filing: Michele Gruber (the “Reporting Person”) (b) Address of Principal Business Office or, if none, Residence: 7800 Susquehanna Street, Suite 505 Pittsburgh, Pennsylvania 15208 (c) Citizenship: United States of America (d) Title of Class of Securities: Common stock, par value $0.0001 per share, of the Issuer (e) CUSIP Number: 53630L100 CUSIP No. 53630L100 13G Page 4 of 6 Pages
If This Statement is Filed Pursuant to §§240.13d-1(b)
Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: Not applicable.
Ownership
Item 4. Ownership. (a) Amount beneficially owned: 365,000 (b) Percent of class: 5.5% (c) Number of shares as to which the Reporting Person has: a. Sole power to vote or to direct the vote: 365,000 b. Shared power to vote or to direct the vote : 0 c. Sole power to dispose or direct the disposition of: 365,000 d. Shared power to dispose or direct the disposition: 0
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class. Not applicable.
Ownership of More than Five Percent on Behalf of
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. CUSIP No. 53630L100 13G Page 5 of 6 Pages
Identification and Classification of the Subsidiary
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.
Identification and Classification of Members of the
Item 8. Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group. Not applicable.
Certification
Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. CUSIP No. 53630L100 13G Page 6 of 6 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 7, 2024 /s/ Michele Gruber Name: Michele Gruber